CytomX Therapeutics, Inc. Quarterly Weighted Average Number of Shares Outstanding, Basic from Q1 2019 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
CytomX Therapeutics, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q1 2019 to Q3 2024.
  • CytomX Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending September 30, 2024 was 85.1M shares, a 5.4% increase year-over-year.
  • CytomX Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 73.8M shares, a 12.3% increase from 2022.
  • CytomX Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 65.7M shares, a 2.48% increase from 2021.
  • CytomX Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 64.1M shares, a 39% increase from 2020.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 85.1M +4.36M +5.4% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q2 2024 84.9M +18.3M +27.6% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 82M +15.8M +23.8% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-08
Q4 2023 73.8M +8.07M +12.3% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-11
Q3 2023 80.7M +14.8M +22.5% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 66.5M +993K +1.52% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 66.2M +855K +1.31% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-08
Q4 2022 65.7M +444K +0.68% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-11
Q3 2022 65.9M +704K +1.08% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-07
Q2 2022 65.5M +487K +0.75% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 65.4M +4.43M +7.26% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 65.3M +18.7M +40.1% Oct 1, 2021 Dec 31, 2021 10-K/A 2023-03-27
Q3 2021 65.2M +19M +41.2% Jul 1, 2021 Sep 30, 2021 10-K/A 2023-03-27
Q2 2021 65.1M +19M +41.3% Apr 1, 2021 Jun 30, 2021 10-K/A 2023-03-27
Q1 2021 61M +15.2M +33.3% Jan 1, 2021 Mar 31, 2021 10-K/A 2023-03-27
Q4 2020 46.6M Oct 1, 2020 Dec 31, 2020 10-K/A 2023-03-27
Q3 2020 46.2M Jul 1, 2020 Sep 30, 2020 10-K/A 2023-03-27
Q2 2020 46.1M Apr 1, 2020 Jun 30, 2020 10-K/A 2023-03-27
Q1 2020 45.7M +601K +1.33% Jan 1, 2020 Mar 31, 2020 10-K/A 2023-03-27
Q1 2019 45.1M Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.